27% growth in prescriptions dispensed over prior quarter; 147% growth over comparable quarter in 2022. 5 consecutive quarters of double-digit growth. Click here to learn more ›

Phase IIa Study of the NPR-Agonist, PL-3994, in Healthy Adult Volunteers with Controlled Hypertension

Leave a Reply

Scroll to Top